Commonwealth Equity Services
IBRX icon

Commonwealth Equity Services’s ImmunityBio IBRX Stock Holding History

Commonwealth Equity Services’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
143,716
+459
+0.3% +$3.47K ﹤0.01% 2527
2026
Q1 		$1.1M Buy
143,257
+67,481
+89% +$462K ﹤0.01% 2538
2025
Q4 		$150K Buy
75,776
+3,280
+5% +$7.43K ﹤0.01% 4045
2025
Q3 		$178K Buy
72,496
+17,640
+32% +$45.4K ﹤0.01% 3977
2025
Q2 		$145K Buy
54,856
+24,334
+80% +$65.4K ﹤0.01% 3997
2025
Q1 		$92K Buy
30,522
+1,567
+5% +$4.75K ﹤0.01% 4004
2024
Q4 		$74K Buy
28,955
+8,380
+41% +$34.9K ﹤0.01% 3947
2024
Q3 		$77K Buy
20,575
+2,400
+13% +$11.1K ﹤0.01% 3897
2024
Q2 		$115K Buy
18,175
+7,135
+65% +$47K ﹤0.01% 3789
2024
Q1 		$59K Buy
11,040
+855
+8% +$3.87K ﹤0.01% 3868
2023
Q4 		$51K Buy
+10,185
New +$32K ﹤0.01% 3755
2022
Q2 		– Sell
-13,108
Closed -$73K – 3735
2022
Q1 		$73K Buy
+13,108
New +$80.4K ﹤0.01% 3540

Other funds holding IBRX

DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
LCGC
Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Commonwealth Equity Services's IBRX Position: Q2 2026 in Review

Commonwealth Equity Services increased its ImmunityBio (IBRX) stake by 0.32% in Q2 2026, buying an estimated $3.47K and bringing the position to 143,716 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Commonwealth Equity Services first reported a position in IBRX in Q1 2022 and has held it in 12 quarters since. 122 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Commonwealth Equity Services held 143,716 shares of ImmunityBio worth $1.26M as of Q2 2026.
  • Commonwealth Equity Services bought 459 ImmunityBio shares in Q2 2026, an estimated $3.47K.
  • ImmunityBio made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2527 holding.
  • Commonwealth Equity Services first reported a position in ImmunityBio in Q1 2022 and has held it in 12 quarters since.
  • 122 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.